熱景生物(688068.SH):擬以1.53億元取得翱鋭生物38.099%股權
格隆匯12月13日丨熱景生物(688068.SH)公佈,公司(“投資方”)與杭州翱鋭生物科技有限公司(“翱鋭生物”或“標的公司”)及其股東簽訂《股權轉讓協議》、《投資協議》,公司通過股權轉讓、認繳新增註冊資本的方式,以1.53億元人民幣的價格取得翱鋭生物38.0993%的股權,相較翱鋭生物2021年10月末經審計的淨資產2873.038萬元人民幣,其溢價率約為13.99倍。
其中,公司自標的公司原股東君聯益康、星闊醫聯、險峯三號、天創白藥、天創泉鑫、翱鋭智康、天創鼎鑫、天創榮鑫、雲旗創業、天津欣昌處,以合計1.23億元的價格受讓標的公司合計33.1081%的股權(對應255.6126萬元註冊資本)。
前述股權轉讓完成後,公司擬投資3000萬元,認繳標的公司新增註冊資本62.252萬元,其中人民幣62.252萬元計入標的公司註冊資本,人民幣2937.748萬元計入標的公司資本公積。
本次交易完成後,標的公司註冊資本增至834.3067萬元,公司將持有標的公司38.0993%股權(對應317.8651萬元註冊資本),標的公司將成為公司的參股公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.